In a landmark development, Schrödinger, Inc. has entered into a multi-target research collaboration and expanded software licensing agreement with Novartis AG, potentially valued at up to $2.5 billion. This strategic alliance aims to leverage Schrödinger’s advanced computational platform to accelerate drug discovery and development across various therapeutic areas. Under the terms of the agreement, Schrödinger […]
Actinogen Medical has raised 11.1 million AUD in a significant capital raise led by its CEO, Dr. Steven Gourlay, who personally invested 1 million AUD. The funds are aimed at accelerating the pivotal Phase 2b/3 trial for its promising Alzheimer’s treatment, Xanamem. This decisive move aims to fast-track patient enrolment and bring the potential breakthrough […]
Fresenius SE & Co. KGaA, a global healthcare company headquartered in Germany, announced the divestment of its intravenous (IV) manufacturing site in Chile, Laboratorio Sanderson S.A., to Medifarma, a pharmaceutical company based in Peru with a strong footprint in Latin America. The divestment aligns with Fresenius Kabi’s ongoing strategy to streamline its global production network […]
Sun Pharmaceutical Industries Limited has introduced STARIZO (Tedizolid Phosphate) to the Indian market, a novel antibacterial treatment targeting Acute Bacterial Skin and Skin Structure Infections (ABSSSI), particularly those caused by drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). This launch represents a significant advancement in addressing the growing concern of antibiotic-resistant infections in India. Skin […]
Zydus Lifesciences Limited, a major player in the global pharmaceutical industry, has entered a pivotal partnership by acquiring a 50% stake in Sterling Biotech Limited from Perfect Day Inc., a leading innovator in the field of fermentation-based proteins. This strategic acquisition signals Zydus’ foray into the rapidly growing market for sustainable, animal-free protein, aligning with […]
Lupin Limited, a global pharmaceutical leader, has officially divested its U.S. Commercial Women’s Health Specialty Business to Evofem Biosciences, Inc., a company specializing in women’s health. This strategic move involves the transfer of the commercial rights for SOLOSEC (secnidazole) 2g oral granules, a single-dose antimicrobial treatment for bacterial vaginosis (BV) and trichomoniasis. Under the terms […]
Alembic Pharmaceuticals Limited has achieved a significant milestone by securing tentative approval from the US Food & Drug Administration (USFDA) for its Selexipag for Injection, 1,800 mcg/vial. This approval, a critical step in the generic drug application process, marks Alembic’s potential entry into the U.S. market with a generic version of Uptravi for Injection, originally […]
Zydus Lifesciences Limited has achieved a significant milestone with the tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil Tablets, in 40 mg and 80 mg dosages. This medication is an angiotensin II receptor blocker (ARB) specifically used for the treatment of hypertension to lower blood pressure, thereby reducing […]
Kirloskar Pneumatic Company Ltd. (BSE: 505283, NSE: KIRLPNU), a prominent entity in the air, refrigeration, and gas compressor sectors, has signed a memorandum of understanding (MoU) to acquire a majority stake (above 51%) in Systems & Components India Private Ltd. (S&C). This move marks a significant strategic expansion for Kirloskar Pneumatic Company Ltd. into the […]
Global pharmaceutical giant, Lupin Limited, announced the appointment of Abdelaziz Toumi (commonly known as Abdel) as the Chief Executive Officer of its newly established subsidiary, Lupin Manufacturing Solutions (LMS). Based in Switzerland, Abdel brings a robust mix of scientific and commercial expertise to LMS, which is set to spearhead the development, manufacture, and sale of […]